Incidence of breakthrough COVID-19 in patients with hematological disorders who received pre-exposure prophylaxis with tixagevimab-cilgavimab: a retrospective study in Japan.

ABSTRACT:

SUBMITTER: Haraguchi M 

PROVIDER: S-EPMC10471491 | biostudies-literature | 2023 Sep

REPOSITORIES: biostudies-literature